Covista demonstrates stabilization, with Q3 FY2026 revenue up 4.5% and positive enrollment trends across key segments. Chamberlain enrollment reached record levels, but revenue growth remains modest; expansion plans could support future growth, though not aggressively priced in. Management raised FY2026 revenue and adjusted EPS guidance, signaling confidence in earnings power despite margin pressures and regulatory risks.